Hormone—receptor interactions: Melanotropic activities of covalent serum albumin complexes with α-melanotropin, α-melanotropin fragments, and enkephalin  by Eberle, Alex et al.
Volume 80, number 2 FEBS LETTERS August 1977 
HORMONE-RECEPTOR INTERACTIONS: MELANOTROPIC ACTIVITIES OF COVALENT 
SERUM ALBUMIN COMPLEXES WITH a-MELANOTROPIN, wMELANOTROPIN 
FRAGMENTS, AND ENKEPHALIN 
Alex EBERLE, Verena Marly KRIWACZEK and Robert SCHWYZER 
Institute of Molecular Biology and Biophysics, Swiss Federal Institute of Technology (ETH), CH-8093 Ziirich, Switzerland 
Received 22 June 1977 
1. Introduction 
The investigation of the biological properties of 
about 60 cu-melanotropin analogues and fragments has 
led to the conclusion that this tridecapeptide consists 
of two message sequences which are capable of trigger- 
ing the hormonal stimulus independently of one 
another [l-3] . The first message sequence is centered 
around -His-Phe-Arg-Trp- [4] and the second 
within the C-terminal tetrapeptide, -Gly-Lys-Pro- 
Val.NH2 [l] . The N-terminal tetrapeptide, Ac-Ser- 
Tyr-Ser-Met.OH, is devoid of melanotropic activity; 
it potentiates, however, the activity of the C-terminal 
nonapeptide about loo-fold [2] : 
A recent claim by Medzihradszky and 
Medzihradszky-Schweiger [S] that the N-terminal 
tetrapeptide,‘as well as a number of peptides related 
to the enkephalins, exhibit tielanosome-dispersing 
properties necessitated a re-investigation of our results. 
At the same time the question should be answered 
whether the fragments of ru-MSH elicit their stimulus 
by the same mechanism as the parent hormone, 
namely by acting on a cell surface membrane receptor 
[6] . To this end, (u-MSH derivatives and fragments 
have been attached covalently to human serum 
albumin, and the complexes have been purified, 
analyzed and tested for melanotropic activity in 
Ac.Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val.NH2 a-melanotropin 
potentiation 1st message sequence 2nd message sequence 
This report has partially been presented at the EMBO Work- 
shop on ‘Hormone Fragments and Disease’, Leiden, May 
2. Materials and methods 
1518,1977 
Abbreviations: Amino acids and peptides: according to the 
tentative rules and recommendations of the IUPAC-IUB 
Commission on Biochemical Nomenclature, Eur. J. Biochem. 
(1972) 27, 201-207. a-MSH = a-melanotropin (ol-melano- 
cyte-stimulating hormone); a-MSH,_,, = cu-melanotropin- 
(S-13)-nonapeptide; ar-MSH,_,, = cY-melanotropin-(9-13)- 
pentapeptide; Pfp = ar-pentafluoro phenylalanine 
vitro. 
(II-MSH, its fragments, and the enkephalin deriva- 
tives were synthesized by a classical approach and 
were analytically pure. They were attached to human 
serum albumin either by reaction of the corresponding 
NLY-bromoacetyl derivatives with thiol-containing 
albumin (modification of the albumin with S-acetyl 
thiosuccinic acid anhydride [“Cl : 4 to 6 -SH groups 
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per protein molecule) or by formation of a defined 
isopeptide bond between hormone and protein [7]. 
The complexes were purified by dialysis, electro- 
dialysis, and column chromatography, and were 
analyzed by chromatography and electrophoresis. 
The coupling rate ranged between 4 and 6 peptide 
molecules per protein molecule as determined with 
tritium-labelled a-MSH derivatives. Details of these 
syntheses and protein modifications will be described 
elsewhere (Eberle et al., in prep. for Helv. Chim. Acta). 
The melanotropic activity of the complexes and of 
the corresponding free,W-acetylated peptides was 
determined in vitro using the reffectometric assay of 
Shizume et al. [8] with some modifications [l] . All 
assays were performed with specimens of Rana pipiens 
(northern), 7.5-9 cm long, which had been kept 
under constant illumination for at least 48 h preceding 
the experiment. The values of melanotropic activities 
are the means of the measurements of twelve different 
skins, four skins each, at three different concentrations. 
The melanotropic activity of the tetrapeptide, HSer- 
Tyr-Ser-Met.OMe, HCl, was tested furthermore by 
the Anolis skin assay [9] by Drs Coert, Greven, and 
Meijer (Organon, Oss, The Netherlands). 
The time-response curves of the peptide-protein 
complexes and of the free peptides were measured 
in the following way: the change of reflectance of 
twenty frog skins for each substance was recorded 
every 5 min during stimulation with hormone and 
during the washing phase. The values were computed 
as the percentage of the total change for each skin 
and their means represented by the curves of tig.1. 
3. Results 
Melanotropic potencies of the free tridecapeptide, 
of its message and potentiator sequences, and of the 
corresponding peptide-protein complexes are listed 
in table 1. The amino acid sequence of a-MSH was 
altered at its N-terminal part in order to obtain a more 
suitable compound for the reaction with bromo- 
acetate: [D-Ala’, Gly3, Nva4]a-MSH exhibits a 
biological activity of 2 X lo9 U/mmol (Bl). The 
corresponding albumin-MSH complex reaches 8 X lOa 
U/mmol (Al), i.e. 45% of the potency of the free 
peptide. Similar relationships also hold for the 
C-terminal nonapeptide (B2 vs. A2) and for the two 
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Fig.1. Time dependence of the melanotropic response of 
20 Rana pipiens skins each for (r-MSH (o-o-o), AC-Lys- 
Pro-Val.NH, (o), albumin-[D-Ala’, Gly3, Nva4]a-MSH 
(A----A), and albumin*-MSH,_,, (v), during prolonged 
incubation and wash phases. 
message sequences, -Glu-His-Phe-Arg-Trp-Gly.OH 
(B3 vs. A3) and -Trp-Gly-Lys-Pro-Val.NH2 (B4 
vs. A4), this in spite of the considerably higher con- 
centrations necessary due to’the much lower potencies 
of the shorter peptides. 
The N-terminal tetrapeptide, HSer-Tyr-Ser-Met. 
MetaOMe, HCI (B5), is devoid of melanotropic activity 
in the Rana as well as in the Anolis skin assays (in the 
latter even in very high concentrations: 10 to 100 
mg/ml); no difference can be observed when the tetra- 
peptide is covalently attached to albumin (AS). 
N(o)-Acetyl-enkephalin-amide (B6) lacks any melano- 
some-dispersing ability either as the free peptide (B6) 
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Table 1 
August 1917 
Melanotropic activities of covalent complexes between human serum albumin and or-MSH-peptides (A) and of the 
corresponding free, p-acetylated peptides (B). X = -CO-CH(CH, -COOH)-S-CH, -CO-, combining NE-amino groups 
of the protein (left), with thep-amino group of the peptide (right) 
Structure of the complexes Biological activity (U/mmol) 
A B A/B 
-X-Ala-Tyr-Gly-Nva-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH, 8x lo* 2x lo9 
0 ALBUMIN -X-Clu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 3x lo8 5x loa 
0 ALBUMIN -X-Glu-His-Phe-Arg-Trp-Gly-OH 2 x lo5 4x lo5 
0 ALBUMIN -X-Trp-Gly-Lys-Pro-Val-NH, IX lo* 6X 10’ 
or in its ‘immobilised’ form (A6). Free [.5-leucine] - 
enkephalin was found to behave similarly. Human 
serum albumin and its thiol-containing form are 
inactive in the concentration range of the assay 
(G lo4 molar). 
The time-response curves for the incubation with 
2 units of hormonal activity (cu-MSH, Ac.Lys--Pro- 
Val.NH2, albumin-[D-Ala’, Gly3, Nva4] cr-MSH and 
albumin-ol-MSH9_r3) and for the wash phase are 
shown in tig.1. Although the concentration of free 
and of covalently bound Ac.Lys-Pro-Val.NH2 is at 
0.45 
0.6 
0.5 
1.1 
- 
- 
least 1000 times greater than that of the corresponding 
forms of [D-Ala’, Gly3, Nva4]a-MSH, the time- 
response patterns of the two free peptides and of the 
two complexes respectively are virtually indistinguish- 
able from one another. Significant differences are 
observed only between the curves of the free and 
protein-bound peptides, especially during the wash 
phase. The slower reaction during the incubation and 
wash phases is a strong indication that the complexes 
are not hydrolysed during their contact with the 
tissue and the melanophores. 
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4. Discussion 
The A/B ratios (complex/free peptide) all lie 
between 0.5 and 1 .l . Considering a factor 2 of bio- 
assay tolerance due mostly to seasonal variations of 
the test animals, it can be stated that almost identical 
molar concentrations of both the free N&-acetylated 
peptides and their corresponding covalent albumin 
complexes are necessary to elicit the same degree of 
melanosome dispersion. This is true for the trideca- 
peptide as well as for the central and the C-terminal 
message sequences. The N-terminal tetrapeptide, 
however, does not exhibit any biological activity 
neither as free peptide nor as peptide-protein complex. 
This fits well into our earlier observations that 
AcSer-Tyr-Ser-Met.OH and HSer-Tyr-Ser-Met- 
Glu-His.OH are devoid of melanotropic activity 
[ 10,111. Thus, cu-MSH consists of two main parts: 
The N-terminal one, Ac-Ser-Tyr-Ser-Met-, 
contains no information to trigger the melanophore 
receptors, but potentiates the biological activity of 
the C-terminal nonapeptide. The latter embodies two 
‘active cores’ or message sequences which seem to 
induce melanosome dispersion in the same way as 
their parent peptides, a-MSHs-1s and o-MSH, namely 
by stimulating a membrane receptor. It appears that 
this mechanism of biological action is much more 
typical of cY-MSH-sequences than has been assumed 
in the report by Medzihradszky and Medzihradszky- 
Schweiger [5] : We have synthesized and tested a 
number of non-MSH peptides that were related to 
angiotensin, oxytocin, and other hormones; they 
were consistently found to be completely inactive 
in the frog skin assay. The same is true for [Leu’ ] - 
enkephalin and N@-acetyl- [Met’] enkephalin-amide 
(table 1). This agrees with the observation [ 121 that 
[MetS]-enkephalin is devoid of melanotropic activity. 
We therefore conclude that, in spite of their low 
affinity, the shorter a-MSH peptides are still recog- 
nized by the receptor with considerable selectivity. 
The specificity may, of course, be relatively lower 
than in the case of the whole tridecapeptide: For 
example, H.Phe-Arg-Leu-Gly.OH is five times more 
active than H.Phe-Arg-Trp-Gly.OH, whereas 
[Leu9]cy-MSH exhibits only 25% of the potency of 
a-MSH [ 1 l] . On the other hand, H.Pfp-Arg-Trp- 
Gly.OH is inactive [2] , demonstrating the importance 
of Phe’ for the interaction with the receptor. 
Up to now, the site of action of a-MSH on melano- 
phores had not been identified unequivocally. It had 
only been shown that a Sepharose-a-MSH complex 
was capable of activating tyrosinase in Cloudman 
mouse melanoma cells [ 131. Such complexes may, 
however, slowly be solvolysed [ 141 , and are therefore 
no definitive proof of a membrane receptor. Recently, 
an internalization of /I-MSH into the cytoplasm of 
melanoma cells was postulated [ 151, but questioned 
shortly afterwards [ 161 . Our own results with frog 
melanophores are consistent with the hypothesis of a 
cell surface receptor for (r-MSH; an internalization of 
the protein-bound hormone seems rather unlikely. 
This conclusion is supported by a recent finding of 
DiPasquale et al. [ 171 that a biologically active 
a-MSH-ferritin-fluorescein isothiocyanate complex 
could not be found in intracellular vesicles of 
Cloudman melanoma cells by electron microscopy. It 
appears that protein-cw-MSH complexes might well 
be suitable for further investigations of melanotropin 
receptors. 
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